DWA
MRNS

Dorsey Wright & Associates’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Dorsey Wright & Associates’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,446
Closed -$26.6K – 336
2023
Q2 		$26.6K Buy
+2,446
New +$26.6K 0.01% 199